Related Experiment Video

Updated: Jul 29, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

11.4K

Innovative antibody therapeutic development in China compared with the USA and Europe

Silvia Crescioli, Janice M Reichert

    Nature Reviews. Drug Discovery
    |November 7, 2025
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
    14:18

    Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

    Published on: October 13, 2023

    2.2K
    Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
    10:25

    Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

    Published on: November 22, 2024

    615

    Related Experiment Videos

    Last Updated: Jul 29, 2026

    Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
    11:11

    Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

    Published on: January 24, 2020

    11.4K
    Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
    14:18

    Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

    Published on: October 13, 2023

    2.2K
    Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
    10:25

    Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

    Published on: November 22, 2024

    615

    Related Concept Videos

    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...

    Articles linked to this work by shared authors, journal, and citation graph.

    Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges.

    Cell·2026

    An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer.

    NPJ precision oncology·2026

    Antibodies to watch in 2026.

    mAbs·2026

    Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha.

    Allergy·2025

    YAbS: The Antibody Society's antibody therapeutics database.

    mAbs·2025

    With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process.

    mAbs·2025

    Artificial intelligence in drug discovery - what it is, where we stand and the path forward.

    Nature reviews. Drug discovery·2026

    Targeting T follicular helper cells for lifelong health.

    Nature reviews. Drug discovery·2026

    Design, simulate, refine: simulation-guided clinical trials for accelerated drug development.

    Nature reviews. Drug discovery·2026

    Targeting Nonclassical Monocytes via Artificial Cell-Microneedles for Precision Psoriasis Therapy.

    Advanced materials (Deerfield Beach, Fla.)·2026

    Intranasal delivery of engineered macrophage-membrane-coated nanoparticles with enhanced Dectin-1 expression for targeted therapy of cryptococcal meningitis.

    Biomaterials·2026

    Trends in Meningioma Incidence, Treatment, and Imaging Surveillance.

    JAMA oncology·2026

    Novel Use of Mavacamten in RAF1-Associated Noonan Syndrome With Hypertrophic Cardiomyopathy.

    JACC. Case reports·2026

    Emergence of neutralizing RBD antibodies following Omicron infection with limited activity against ancestral SARS-CoV-2.

    iScience·2026

    Functional and Anatomic Outcomes at 12 Months After Switching to Faricimab in Treatment-Recalcitrant Neovascular Age-Related Macular Degeneration.

    Journal of vitreoretinal diseases·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us